Intravenous ferric carboxymaltose in heart failure with iron deficiency

JAMA

2025-03-30

(Press-News.org) About The Study: In patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death in the overall cohort or in patients with a transferrin saturation less than 20%, or reduce the total number of heart failure hospitalizations vs placebo.

Corresponding Author: To contact the corresponding author, Stefan D. Anker, MD, PhD, email s.anker@cachexia.de.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2025.3833)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Media advisory: This study is being presented at the American College of Cardiology’s Annual Scientific Session.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.3833?guestAccessKey=d0f1994a-91d7-4f6a-aba0-70bee53bf261&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033025

END

ELSE PRESS RELEASES FROM THIS DATE:

Artificial intelligence in the prevention of sudden death

2025-03-30

Many cases of sudden cardiac death could be avoided thanks to artificial intelligence. As part of a new study to be published in European Heart Journal, a network of artificial neurons imitating the human brain was developed by researchers from Inserm, Paris Cité University and the Paris public hospitals group (AP-HP), in collaboration with their colleagues in the USA. During the analysis of data from over 240 000 ambulatory electrocardiograms, this algorithm identified patients at risk of a serious arrhythmia that was capable of triggering cardiac arrest within the following 2 weeks in over 70% of cases. Each ...

Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes

2025-03-29

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings. A new clinical trial, co-led by endocrinologist and diabetes expert John Buse, MD, PhD, and interventional cardiologist Matthew Cavender, MD, MPH, at the UNC School of Medicine has shown that the oral form of semaglutide can significantly reduce cardiovascular events in people with type 2 diabetes, atherosclerotic cardiovascular disease, and/or ...

Prothrombin complex concentrate vs frozen plasma for coagulopathic bleeding in cardiac surgery

2025-03-29

About The Study: In this unblinded randomized clinical trial, prothrombin complex concentrate had superior hemostatic efficacy and safety advantages to frozen plasma among patients requiring coagulation factor replacement for bleeding during cardiac surgery. Corresponding Author: To contact the corresponding author, Keyvan Karkouti, MD, email keyvan.karkouti@uhn.ca. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2025.3501) Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, ...

Who needs a statin? New study compares prescribing recommendations based on traditional risk factors vs. coronary artery calcium scoring

2025-03-29

A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate patients who are at risk of developing coronary heart disease and which patients would benefit from taking a statin medication to lower cholesterol. Currently, cardiologists determine a patient’s need for a statin based on traditional risk factors, using the Pooled Cohort Equation (PCE), which calculates coronary risk by assessing the risk factors of age, sex, total and HDL cholesterol levels, blood pressure, and whether someone ...

Finerenone and atrial fibrillation in heart failure

2025-03-29

About The Study: The efficacy of finerenone was consistent regardless of atrial fibrillation status in this study. New-onset atrial fibrillation was associated with a substantially higher risk of subsequent outcomes. Corresponding Author: To contact the corresponding author, John J. V. McMurray, MD, email john.mcmurray@glasgow.ac.uk. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamacardio.2025.0848) Editor’s Note: Please see the article for additional information, including other authors, ...

Low coronary artery calcium score is associated with an excellent prognosis regardless of a person’s age, new study finds

2025-03-29

Having a coronary artery calcium (CAC) score of zero has generally been accepted as a marker of a very low risk of having a cardiac event within the next five years. However, age is a strong contributor to coronary risk, with risk increasing markedly as people age. Whether age-related risk factors diminish the low risk predicted by a zero coronary artery calcium score has been uncertain – until now. A large new study of more than 40,000 patients from heart researchers at Intermountain Health in Salt Lake City finds that a zero coronary artery calcium score continues to be an accurate indicator of a low risk for a coronary ...

Groundbreaking consensus statement on conduction system pacing released: a major milestone in the evolution of pacing therapy

2025-03-29

Vienna, 30 March 2025– The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The document was officially presented today at the EHRA 2025 congress in Vienna and simultaneously published in EP Europace. For over 50 years, right ventricular pacing has been a standard treatment for slow heart rhythms. However, in some patients, this approach can lead to reduced heart function and even heart failure. Furthermore, biventricular pacing ...

Nuclear monitoring system suggests landslide cut off internet in west Africa

2025-03-29

Hydroacoustic signals captured by the world’s international nuclear monitoring system suggest an underwater landslide may have broken communications cables and disrupted internet traffic in west African countries for several weeks in March 2024. Researchers used data collected by hydrophones installed by the International Monitoring System of the Comprehensive Nuclear-Test-Ban Treaty Organization (CTBTO) to determine the location of the possible landslide, placing it along the steep slopes of Trou Sans Fond Canyon offshore of Ivory Coast. The proposed landslide corresponds with the timing and location of four broken cables in the canyon, according to Vaibhav Vijay Ingale of UC ...

PNNL scientist elected AAAS fellow

2025-03-29

RICHLAND, Wash.—Chemist Zheming Wang, whose research largely focuses on the chemistry underlying radioactive and advanced energy materials, as well as critical elements, has been elected as a Fellow of the American Association for the Advancement of Science—the highest honor the society bestows. AAAS is the world's largest multidisciplinary scientific society with a mission to “advance science, engineering, and innovation throughout the world for the benefit of all people.” AAAS notes that Fellows are celebrated for contributions that span ...

American College of Cardiology recognizes five JACC Rocket Fuel Consultants

2025-03-28

The American College of Cardiology will honor five cardiovascular experts with the JACC Rocket Fuel Consultant Award for fueling JACC’s mission to provide high-quality, pertinent research and improve heart health for all. The awardees will be recognized during ACC’s Annual Scientific Session (ACC.25) in Chicago. This is the first year of the JACC Rocket Fuel Consultant Award. The JACC consultant program invites experts to provide comprehensive assessments of a submission’s quality, importance and impact. Their contributions streamline the review process and ensure that JACC maintains its commitment to high-quality research. The 2025 JACC Rocket ...

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Intravenous ferric carboxymaltose in heart failure with iron deficiency

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: